Dedicated Staff and Cutting-Edge Technology Helps Solve Pain’s Many Mysteries
By Brandon Levy
Thursday, May 5, 2022
For such a common ailment, pain remains a significant mystery. Part of the challenge of studying it is that it occurs in so many conditions and can vary from a mild ache to life-altering misery. Fortunately for both pain patients and IRP researchers studying pain, the NIH Pain Research Center has the technology and expertise to power new discoveries about pain in its many, complex forms.
On March 31 and April 1, NIH’s National Center for Complementary and Integrative Health (NCCIH) hosted a two-day virtual symposium titled “Tackling Pain at the National Institutes of Health: Updates From the Bench, the Clinic, and the New NIH Pain Research Center,” which featured presentations from a number of IRP scientists exploring important questions related to pain. Read on to learn more about some of the research discussed during that event, including efforts examining pain in patients with rare diseases, early-phase clinical trials of a new pain treatment, and investigations of how psychological factors can affect the way people experience pain.
NIH Pain Research Center Shines Light on a Common and Complex Ailment
By Brandon Levy
Monday, April 25, 2022
At one time or another, practically everyone has had a headache, stubbed their toe, or scorched their mouth on a hot slice of pizza, making pain one of the few experiences that essentially all people share. Despite its everyday nature, however, pain remains extremely mysterious. Even more enigmatic is chronic pain, which may not even stem from a clearly defined source yet affects more than a fifth of American adults.
Given the near-universality of pain and its huge social and economic burden, it’s no surprise that many researchers at NIH study it. Yet, prior to 2019, there was no central, shared entity in the NIH’s Intramural Research Program that united the many scientists performing this important work. That was the year NIH’s Pain Research Center was established, with the help of funding from the NIH Director’s Challenge Innovation Awards.
IRP Research Leads to First FDA-Approved Therapy for Merkel Cell Carcinoma
By Melissa Glim
Tuesday, May 4, 2021
May is Skin Cancer Awareness Month. Skin cancers are the most common cancer in the U.S., affecting as many as five million people every year. Yet the rarest of these cancers is also one of the deadliest. Merkel cell carcinoma affects about 3,000 Americans each year, and until recently a lack of effective treatments meant only half of patients survived five years or longer after diagnosis. The median survival was nine months.
This bleak outlook changed radically in 2017 with the US Food and Drug Administration (FDA) approval of a new immunotherapy drug called avelumab. Developed through a collaboration between IRP researchers and the pharmaceutical company EMD Serono, Inc., and marketed as Bavencio, avelumab was the first treatment approved specifically for Merkel cell carcinoma.
Program Boosts Initiatives Supporting Researchers Across NIH
By Brandon Levy
Tuesday, September 1, 2020
From Superbowl-winning football teams to comic book cohorts like The Avengers, combining the efforts of multiple talented individuals is a proven strategy for achieving remarkable results. It may come as no surprise, then, that the NIH’s Intramural Research Program (IRP) strongly encourages collaborations that breach the boundaries of its 24 Institutes and Centers. One example of these efforts is the Director’s Challenge Innovation Awards Program, which since 2009 has funded high-impact scientific projects that bring together researchers from across the IRP.
The IRP’s Mario Roederer and Robert Seder Discuss the Science Behind the Headlines
By Brooke Worthing, Kiara Palmer
Monday, March 23, 2020
Some say that if something’s not broken, then don’t fix it, but that doesn’t mean there’s no room for improvement. At least, those were the thoughts of IRP senior investigators Mario Roederer, Ph.D., and Robert Alan Seder, M.D., who recently found that the century-old tuberculosis (TB) vaccine is far more effective when administered via injection into a vein (IV) rather than into the skin, which has long been the standard way it is given. This major breakthrough received extensive media coverage, including a story in the New York Times. We went Behind the Headlines to get the inside scoop on this potentially life-saving discovery.
Scientific Team-Up Identifies Source of Tumor Drug Resistance
By Brooke Worthing
Tuesday, December 17, 2019
It’s an unfortunate reality that nearly everyone knows somebody whose life has been affected by cancer. However, a discovery by two researchers who met by chance years ago might one day help more cancer patients overcome their disease. Two scientific teams led by the IRP’s Craig Thomas, Ph.D., a group leader at the NIH’s National Center for Advancing Translational Sciences (NCATS), and Daniel Starczynowski, Ph.D., of Cincinnati Children’s Hospital Medical Center, recently published a study describing a possible breakthrough in the fight against acute myeloid leukemia (AML), a form of cancer responsible for nearly 11,000 deaths per year in the United States.
By L. Michelle Bennett, Christophe Marchand
Tuesday, August 13, 2019
Overcoming complex diseases, from viruses to cancers to mental health and beyond, requires teams of people in a variety of settings. At the NIH IRP, researchers with very different expertise and backgrounds tackle the most difficult biomedical questions by working together.
If you’re planning to engage in team science or collaborations of any sort, keep these four words in mind, as they are what newly organized team members should expect on the road to success: forming, storming, norming and performing. Each step, outlined in this blog entry with insights from two leading IRP investigators, is a phase of team development, as originally introduced in the 1960s by Bruce Tuckman (See page 46 of NIH’s Collaboration and Team Science Field Guide).
By L. Michelle Bennett, Christophe Marchand
Tuesday, October 2, 2018
What attracts talented scientists to the IRP? And, once they are here, why do they stay? One major factor is the proximity to brilliant colleagues and collaborative relationships across the spectrum of biomedical research.
Seeking to understand the key elements that contribute to successful team science, we studied a number of NIH research teams to discover the secrets of their success. The results are examined in the second edition of Collaboration and Team Science: A Field Guide, which contains new insights from individuals, teams, and organizations around the world.
What are the 10 Elements of Successful Teams? Read on to find out.
By Simona Patange
Wednesday, June 1, 2016
For many young researchers, spring is the time to make a decision of how to continue with their education and perhaps whether partnering with a lab in the NIH IRP for their dissertation research might be the right path for them. What is it like to be a graduate student at two institutions?
By Angie Abraham, Howard Young
Tuesday, May 10, 2016
Highly talented scientists underlie the innovative biomedical research conducted at the NIH IRP. I asked one of them, Dr. Howard Young, Senior Investigator at the National Cancer Institute’s (NCI) Frederick, Maryland, campus, about how the environment of opportunity, access to resources, and proximity to cutting-edge science influences his work.
